doctor’s meeting

Biktarvy, confirmation of the effect of long-term investigation for 5 years of initial treatment

by
Biktarvy, confirmation of the effect of long-term investigation for 5 years of initial treatment

Biktarvy product photo Five-year long-term data of the HIV-1 drug Biktarvy (ingredient name bictegravir/emtricitabine/tenofovir alafenamide, B/F/TAF) was added to the approval requirements. Gilead Sciences Korea announced on the 27th that the Ministry of Food and Drug Safety on January 30th added clinical information on 5-year long-term data conducted on adults infected with HIV-1 after initial … Read more

Benefits of age before liver cancer treatment… Older people also have a higher prognosis

by
Benefits of age before liver cancer treatment… Older people also have a higher prognosis

Lee Han-ah, planning committee member of the Liver Cancer Association (Division of Gastroenterology, Ewha Womans University Mok-dong Hospital) While the number of elderly patients with liver cancer is increasing, a study has found that the prognosis during treatment intervention is similar to that of non-elderly patients. In particular, in the case of advanced liver cancer … Read more

Cardiovascular disease is the leading cause of death in diabetes? In fact, more cancers

by
Cardiovascular disease is the leading cause of death in diabetes? In fact, more cancers

Cancer, not cardiovascular disease, is the leading cause of death in type 2 diabetes, a new study has found. This breaks the conventional wisdom that the cause of death in diabetes is a cardiovascular disease complication, suggesting the need for a multidisciplinary approach. The results of a study on the mortality rate of patients with … Read more

Daewoong Enblo, selected as a successful case of rapid screening by the Ministry of Food and Drug Safety

by
Daewoong Enblo, selected as a successful case of rapid screening by the Ministry of Food and Drug Safety

Daewoong Pharmaceutical announced that Enblo Tab. was announced as a successful case of rapid product development at the ‘Innovative Pharmaceutical Company GIFT Rapid Review Support Conference’ co-hosted by the Rapid Review Division of the Food and Drug Safety Evaluation Institute and the Korea Pharmaceutical Bio Association at 3:00 pm on the 26th. . An innovative … Read more

GLP-1 raises Ozempic retinopathy… Reconfirmed in large-scale analysis

by
GLP-1 raises Ozempic retinopathy… Reconfirmed in large-scale analysis

The side effect issue of diabetic retinopathy (DR) of type 2 diabetes treatment glucagon-like peptide-1 receptor agonist (GLP-1 RA) has been reconfirmed. At the time of the development of semaglutide, an increase in retinopathy patients was observed in clinical trials, but as a similar trend was found in a meta-analysis involving a total of 60,000 … Read more

Good Cholesterol, HDL, Negative for Bone Health

by
Good Cholesterol, HDL, Negative for Bone Health

Studies have shown that high-density lipoprotein (HDL-C), the cholesterol that is good for cardiovascular health, is negative for bone health. For cardiovascular health, high HDL-C is good, but for bone health, it means you need to find the right trade-off. The results of a study on the association between plasma HDL-C levels and fracture risk, … Read more